IV Levetiracetam versus IV Phenytoin in Childhood Seizures: A Randomized Controlled Trial

Kanika Singh1, Anju Aggarwal1, M M A Faridi1

  • 1Department of Paediatrics, University College of Medical Sciences and GTB Hospital, Delhi - 110095 India.

Insights

Intravenous levetiracetam and phenytoin demonstrate comparable efficacy in preventing recurrent acute seizures in children within 24 hours. Both treatments are effective for pediatric seizure management.

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacology
  • Emergency Medicine

Background:

  • Acute seizures in children require prompt and effective treatment.
  • Intravenous (IV) phenytoin and IV levetiracetam are commonly used antiepileptic drugs.

Purpose of the Study:

  • To compare the efficacy and safety of IV phenytoin versus IV levetiracetam in pediatric patients experiencing acute seizures.

Main Methods:

  • A randomized controlled trial was conducted with 100 children (aged 3-12 years) presenting with acute seizures.
  • Participants received either IV phenytoin (20 mg/kg) or IV levetiracetam (30 mg/kg), with diazepam administered prior to these drugs if seizures persisted.
  • Outcomes included seizure absence within 24 hours, seizure cessation within 20 minutes, cardiorespiratory changes, and therapeutic drug levels.

Main Results:

  • Efficacy was comparable, with 94% of levetiracetam patients and 96% of phenytoin patients remaining seizure-free for 24 hours (P > 0.05).
  • Levetiracetam showed a trend towards faster seizure cessation and less sedation.
  • Therapeutic drug levels were achieved more consistently and rapidly with levetiracetam compared to phenytoin.

Conclusions:

  • IV levetiracetam and IV phenytoin exhibit similar efficacy in preventing 24-hour seizure recurrence in children with acute seizures.
  • Levetiracetam may offer advantages in terms of faster onset and potentially fewer side effects like sedation.
Abstract

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
824
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
541
Diversity of Archaea IV01:29

Diversity of Archaea IV

Hyperthermophilic archaea are a group of extremophiles thriving at temperatures above 80°C, often in hydrothermal vents and volcanic soils where conditions surpass the boiling point of water. At such temperatures, proteins, membranes, and DNA in most organisms degrade, but hyperthermophiles have evolved remarkable adaptations to maintain stability and function.Unique Cellular FeaturesHyperthermophilic membranes are composed of a monolayer of biphytanyl tetraether lipids, which resist...
480
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
297
Diversity of Protists IV01:27

Diversity of Protists IV

Amoebozoa represent a diverse group of terrestrial and aquatic protists that utilize lobe-shaped pseudopodia for locomotion and feeding. This characteristic differentiates them from the Rhizaria, which possess threadlike pseudopodia. The primary classifications within Amoebozoa include gymnamoebas, entamoebas, and the plasmodial and cellular slime molds. Phylogenetic evidence indicates that Amoebozoa diverged from a lineage that ultimately gave rise to fungi and animals.Gymnamoebas and...
1.1K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.8K